NovoCure Ltd
(NAS:NVCR)
$
16.62
0.03 (0.18%)
Market Cap: 1.80 Bil
Enterprise Value: 1.51 Bil
PE Ratio: 0
PB Ratio: 4.98
GF Score: 67/100 Novocure Ltd at Wells Fargo Virtual Healthcare Conference Transcript
Sep 09, 2020 / 12:40PM GMT
Release Date Price:
$85.45
(+4.09%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
I'm Larry Biegelsen, the medical device analyst at Wells Fargo. I'm pleased to introduce the next company in our morning session on day 1 of our 2020 Virtual Health Care Conference, NovoCure. Joining us from the company are the Executive Chairman, Bill Doyle; and Chief Scientific Officer, Dr. Uri Weinberg. In terms of format, it will be a 30-minute fireside chat. So Bill and Uri, welcome, and thank you for joining us.
Uri Weinberg
NovoCure Limited - Chief Science Officer
Thanks for having us, Larry. It's our pleasure to be here.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Good. So we're going to try something a little different. We're going to try to do 1 audience polling question this morning. And we'll prompt the audience at the appropriate time. But Bill, let's quickly touch upon COVID before
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot